CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0034
+0.0001 (3.03%)
At close: Nov 6, 2026
CERO Market Cap
CERO has a market cap or net worth of $258.13 thousand as of November 6, 2026. It is the 50,879th most valuable company in the world and the 7,070th biggest in the United States. Its market cap has increased by 20.24% in one year.
Market Cap
258.13K
Enterprise Value
16.62M
Revenue
n/a
Global Rank
Country Rank
#7,070 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 258.13K, a decrease of -99.88%. That is a compound annual growth rate of -74.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 258.13K | -81.73% |
| Dec 31, 2025 | 1.41M | -87.73% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 411.51K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 337.23K |
| Nextel Medical | 263.46K |
| RegeneRx Biopharmaceuticals | 260.99K |
| Regen BioPharma | 251.29K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 192.58K |